A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction
Joint Authors
Lasker, George F.
Kadowitz, Philip J.
Maley, Jason H.
Source
Advances in Pharmacological and Pharmaceutical Sciences
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-06-27
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70.
Treatment with PDE-5 inhibitors is effective in the majority of men with ED.
However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low.
The pharmacologic actions of three new potential treatments for ED are discussed in this paper: (1) sGC stimulators/activators, (2) Rho-kinase inhibitors, and (3) sodium nitrite.
American Psychological Association (APA)
Lasker, George F.& Maley, Jason H.& Kadowitz, Philip J.. 2010. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction. Advances in Pharmacological and Pharmaceutical Sciences،Vol. 2010, no. 2010, pp.1-10.
https://search.emarefa.net/detail/BIM-988673
Modern Language Association (MLA)
Lasker, George F.…[et al.]. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction. Advances in Pharmacological and Pharmaceutical Sciences No. 2010 (2010), pp.1-10.
https://search.emarefa.net/detail/BIM-988673
American Medical Association (AMA)
Lasker, George F.& Maley, Jason H.& Kadowitz, Philip J.. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction. Advances in Pharmacological and Pharmaceutical Sciences. 2010. Vol. 2010, no. 2010, pp.1-10.
https://search.emarefa.net/detail/BIM-988673
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-988673
